Skip to main content
. 2019 Oct 16;99(1):79–88. doi: 10.1111/aogs.13731

Table 1.

Patient characteristics

  Present cases, n (%)
Total number of cases 13
Age (years), median (range) 31.7 (26.9‐39.9)
Gestational age at diagnosis (wk),a median (range) 22 (6‐30)
Gestational age at delivery (wk), median (range) 32(19‐39)
History of smoking 4 (31%)
Histopathology
 Diffuse type 12 (100%)
 Signet ring cell 8 (67%)
 Intestinal type 0
 Unknown 1
Disease stage at diagnosis
 Stage II 1 (8%)
 Stage IV 12 (92%)
Treatment during pregnancy
 Chemotherapy 6 (46%)
 Surgery with curative intent 1 (8%)
 Exploratory surgery (palliative) 3 (23%)
Deferral of treatment until after delivery 3 (23%)
Obstetrical outcome
 Termination of pregnancy 1 (8%)
 Late miscarriage/IUD 2 (15%)
 Live birth 10 (77%)
 <28 wk 1
 <34 wk 5
 <37 wk 2
 Term 2
Complications
 Preeclampsia 3 (23%)
 Spontaneous preterm delivery 1 (8%)
 Low birthweight (<P10)a 4 (44%)
Mode of delivery
 Vaginal delivery 2 (20%)
 Cesarean section 8 (80%)
Placental metastasis 0
Maternal outcome
 Deceased during pregnancy 1 (8%)
 Alive in 3 mo 9 (69%)
 Alive in 6 mo 7 (54%)
 Alive in 12 mo or more 4 (31%)

Abbreviation: IUD, intrauterine death (deceased with mother).

Excluded 1 patient with recurrent gastric cancer during pregnancy.

a

1 case birthweight unknown.